Non-pharmacological interventions play a big role in managing rheumatoid arthritis (RA) symptoms and improving quality of ...

AbolerIS Pharma has dosed the Phase I study’s first cohort subjects with its humanised anti-CD45 receptor-like protein C ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back ...

Ayurvedic treatment, or Ayurveda, is a holistic practice focusing on diet, exercise, and other lifestyle changes. It may help improve the quality of life for individuals with rheumatoid arthritis.

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Medicaid enrollees with type 2 diabetes face restricted access to newer classes of first-line medications, especially in ...

"ABO21009 is the first antibody of its class to enter clinical trials in Europe and we believe it has great potential as a disease-modifying treatment for RA due to its multi-pronged mechanism of ...

The antibody is tailored for RA patients who have not responded well to existing treatments, including anti-tumour necrosis factor (TNF) therapies. The first-in-human, adaptive design, randomised ...